(Q34966816)

5 August 2017

1 reference

title

Role of radiotherapy in the management of hepatocellular carcinoma: A systematic review (English)

1 reference

adaptive radiation therapy

5 August 2017

main subject

0 references

systematic review

1 reference

inferred from title

hepatocellular carcinoma

1 reference

6

Nikolaos Kelekis

0 references

Vassilis Kouloulias

7

object named as

Vassilis Kouloulias

0 references

author name string

Maria-Aggeliki Kalogeridi

1

1 reference

5 August 2017

Anna Zygogianni

2

1 reference

5 August 2017

George Kyrgias

3

1 reference

5 August 2017

John Kouvaris

4

1 reference

5 August 2017

Sofia Chatziioannou

5

1 reference

5 August 2017

publication date

1 January 2015

1 reference

World Journal of Hepatology

5 August 2017

published in

1 reference

5 August 2017

volume

7

1 reference

5 August 2017

issue

1

1 reference

5 August 2017

page(s)

101-112

1 reference

High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Radiofrequency ablation versus hepatic resection for the treatment of early-stage hepatocellular carcinoma meeting Milan criteria: a systematic review and meta-analysis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Radiofrequency ablation for hepatocellular carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Unusual extrahepatic metastatic sites from hepatocellular carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Feasibility and efficacy of stereotactic ablative radiotherapy for Barcelona Clinic Liver Cancer-C stage hepatocellular carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Hypofractionated radiotheapy using helical tomotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Yttrium 90 microspheres for the treatment of hepatocellular carcinoma.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Effectiveness of high-dose three-dimensional conformal radiotherapy in hepatocellular carcinoma with portal vein thrombosis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Killing effects of different physical factors on extracorporeal HepG2 human hepatoma cells.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Brain metastases from hepatocellular carcinoma: clinical features and prognostic factors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma after liver transplantation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Hepatic radiation toxicity: avoidance and amelioration

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Liver transplantation for the treatment of hepatocellular carcinoma.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

8 July 2018

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Barriers to the successful treatment of liver disease by hepatocyte transplantation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Little response of cerebral metastasis from hepatocellular carcinoma to any treatments

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Bone marrow-derived stem cells in liver repair: 10 years down the line

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Model systems and experimental conditions that lead to effective repopulation of the liver by transplanted cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Proton-beam therapy for hepatocellular carcinoma associated with portal vein tumor thrombosis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma: a systematic review and meta-analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Phase II study of transarterial holmium-166-chitosan complex treatment in patients with a single, large hepatocellular carcinoma.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Radionuclide therapy for hepatocellular carcinoma: indication, cost and efficacy.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Brain metastases from hepatocellular carcinoma: prognostic factors and outcome: brain metastasis from HCC.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Sorafenib in advanced hepatocellular carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

The evolution of liver transplantation for hepatocellular carcinoma (past, present, and future).

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Hepatocellular cancer: a guide for the internist

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Yttrium-90 microspheres for the treatment of hepatocellular carcinoma: a review.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Long-term clinical outcome of phase IIb clinical trial of percutaneous injection with holmium-166/chitosan complex (Milican) for the treatment of small hepatocellular carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Anti-TGF-beta strategies for the treatment of chronic liver disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Management of hepatocellular carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Partial volume tolerance of the liver to radiation.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Treatment of hepatocellular carcinoma by means of radiopharmaceuticals

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Radiotherapy for painful bone metastases from hepatocellular carcinoma.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Global cancer statistics, 2002

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Radiation therapy for adrenal gland metastases from hepatocellular carcinoma.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Intracranial metastasis of hepatocellular carcinoma: review of 45 cases

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Comparison between chemoembolization combined with radiotherapy and chemoembolization alone for large hepatocellular carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Radiotherapy for osseous metastases from hepatocellular carcinoma: a retrospective study of 57 patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Analysis of clinical complication data for radiation hepatitis using a parallel architecture model

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Tolerance of normal tissue to therapeutic irradiation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Anticoagulation and high dose liver radiation.A preliminary report

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma

8 July 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: subset analyses of the phase III Sorafenib Asia-Pacific trial

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

Defining prognostic factors of survival after external beam radiotherapy treatment of hepatocellular carcinoma with lymph node metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

Prognostic factors and prevention of radioembolization-induced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

Intra-arterial injection of iodine-131-labeled lipiodol for treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

Intra-arterial injection of 131I-labeled Lipiodol for advanced hepatocellular carcinoma: a 7 years' experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies--mature results of the French Phase II RTF-1 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

Local radiotherapy for patients with unresectable hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

Three-dimensional conformal radiotherapy for hepatocellular carcinoma in patients unfit for resection, ablation, or chemotherapy: a retrospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

The role of transcatheter arterial embolization in patients with resectable hepatocellular carcinoma: a nation-wide, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

Radiation therapy in combination with transcatheter arterial chemoembolization for hepatocellular carcinoma with extensive portal vein involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

Acceptable toxicity after stereotactic body radiation therapy for liver tumors adjacent to the central biliary system

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

Stereotactic body radiotherapy for primary hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

Stereotactic radiotherapy of hepatocellular carcinoma: preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

Portal vein thrombosis in hepatocellular carcinoma: age and sex distribution in an autopsy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

Proton beam therapy for hepatocellular carcinoma: the University of Tsukuba experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

Proton beam therapy for large hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

The anti-hepatoma effect of nanosized Mn-Zn ferrite magnetic fluid hyperthermia associated with radiation in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

Analysis of radiation-induced liver disease using the Lyman NTCP model.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

Selenium and vitamin E modulates radiation-induced liver toxicity in pregnant and nonpregnant rat: effects of colemanite and hematite shielding.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

Extrahepatic Metastases of Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

Stereotactic body radiation therapy combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Yttrium-90 microspheres for the treatment of hepatocellular carcinoma.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Treatment of hepatocellular carcinoma with transcatheter arterial embolization. Analysis of prognostic factors

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4295187

Treatment of early hepatocellular carcinoma: Towards personalized therapy

26 October 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

Epidemiology of Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I1.101

Clinical results and risk factors of proton and carbon ion therapy for hepatocellular carcinoma

21 January 2018

1 reference

12 December 2020

Stereotactic body radiation therapy in recurrent hepatocellular carcinoma

1 reference

12 December 2020

Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venoocclusive disease

1 reference

12 December 2020

Liver transplantation for hepatocellular carcinoma

1 reference

12 December 2020

Long-term results of hepatic artery fluorodeoxyuridine and conformal radiation therapy for primary hepatobiliary cancers

1 reference

12 December 2020

Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes

1 reference

12 December 2020

Formation of hilar collaterals or cavernous transformation after portal vein obstruction by hepatocellular carcinoma. Observations in ten patients

1 reference

12 December 2020

A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge

1 reference

12 December 2020

Report of the 15th follow-up survey of primary liver cancer

1 reference

12 December 2020

Stereotactic hypofractionated radiation therapy as a bridge to transplantation for hepatocellular carcinoma: clinical outcome and pathologic correlation

1 reference

12 December 2020

Clinical study of transarterial chemoembolization combined with 3-dimensional conformal radiotherapy for hepatocellular carcinoma

1 reference

12 December 2020

Conformal high-dose radiation plus intraarterial floxuridine for hepatic cancer

1 reference

12 December 2020

Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors

1 reference

12 December 2020

Experience with liver resection after hepatic arterial chemoembolization for hepatocellular carcinoma

1 reference

12 December 2020

Conformal radiation therapy for portal vein tumor thrombosis of hepatocellular carcinoma

1 reference

12 December 2020

Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma

1 reference

12 December 2020

Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma

1 reference

12 December 2020

Hepatocellular carcinoma: current surgical management

1 reference

12 December 2020

Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis

1 reference

12 December 2020

Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients

1 reference

12 December 2020

Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization

1 reference

12 December 2020

HEPATIC INJURY FOLLOWING IRRADIATION--A MORPHOLOGIC STUDY--

1 reference

12 December 2020

Radiotherapy after transcatheter arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumor thrombus

1 reference

12 December 2020

Radiotherapy for lymph node metastases in patients with hepatocellular carcinoma: retrospective study

1 reference

12 December 2020

Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma

1 reference

12 December 2020

Pathogenesis of veno-occlusive liver disease after radiation

1 reference

12 December 2020

Protons or Photons for Hepatocellular Carcinoma? Let's Move Forward Together

1 reference

12 December 2020

Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma

1 reference

12 December 2020

Radionuclide therapy of hepatocellular carcinoma

1 reference

12 December 2020

Influence of liver toxicities on prognosis after stereotactic body radiation therapy for hepatocellular carcinoma

1 reference

12 December 2020

Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres

1 reference

12 December 2020

Treating and downstaging hepatocellular carcinoma in the caudate lobe with yttrium-90 radioembolization

1 reference

12 December 2020

Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the Cox proportional hazard model

1 reference

12 December 2020

Identifiers

DOI

10.4254/WJH.V7.I1.101

1 reference

5 August 2017

1 reference

5 August 2017

1 reference